Predictors of Good Long-Term Renal Outcomes in Lupus Nephritis: Results from a Single Lupus Cohort

被引:15
作者
Fung, William A. [1 ]
Su, Jiandong [1 ]
Touma, Zahi [1 ]
机构
[1] Univ Toronto, TorontoWestern Hosp, Ctr Prognosis Studies Rheumat Dis, Lupus Clin, Toronto, ON, Canada
关键词
MYCOPHENOLATE-MOFETIL; INDUCTION TREATMENT; CREATININE RATIO; REVISED CRITERIA; DOUBLE-BLIND; ERYTHEMATOSUS; EFFICACY; SAFETY; CYCLOPHOSPHAMIDE; CLASSIFICATION;
D O I
10.1155/2017/5312960
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
This study aims to elucidate the predictive capabilities of proteinuria, serum creatinine (Cr), and urine RBCs (uRBCs) with respect to long-termrenal outcomes in lupus nephritis (LN) in patients followed in clinic. Methods. A retrospective analysis was performed on patients with LN. We evaluated the ability of proteinuria, serum Cr, and uRBCs at 12 months to predict good long-term renal outcomes defined as serum Cr <= 100 mmol/L and kidney transplant/dialysis-free at the 7th year. Receiver operator characteristic curves were generated for proteinuria, serum Cr, and uRBCs to study their ability to predict good long-term outcomes and to identify their best cut-off. Descriptive statistics studied the pattern of change of proteinuria and serum Cr. Results. Proteinuria of 0.6 g/d and Cr of 83 mmol/L performed independently moderately well in predicting good long-term renal outcomes while uRBC was less accurate. Combining serum Cr to proteinuria gave a small increase in positive predictive value with a trade-off in sensitivity. Proteinuria changed within the first year whereas serum Cr changed until the 7th year. Conclusions. Both proteinuria and Cr predict good long-term renal outcomes in LN. Proteinuria's ability to change faster at 12 months makes it a favorable endpoint for clinical trials and research studies.
引用
收藏
页数:8
相关论文
共 26 条
[1]   Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis [J].
Appel, Gerald B. ;
Contreras, Gabriel ;
Dooley, Mary Anne ;
Ginzler, Ellen M. ;
Isenberg, David ;
Jayne, David ;
Li, Lei-Shi ;
Mysler, Eduardo ;
Sanchez-Guerrero, Jorge ;
Solomons, Neil ;
Wofsy, David .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (05) :1103-1112
[2]   Treatment of Lupus Nephritis With Abatacept [J].
Askanase, Anca D. ;
Byron, Margie ;
Keyes-Elstein, Lynette L. ;
Cagnoli, Patricia C. ;
McCune, W. Joseph ;
Chatham, W. Winn ;
Contreras, Gabriel ;
Daikh, David I. ;
Dall'Era, Maria ;
Wofsy, David ;
Davidson, Anne ;
Diamond, Betty ;
Mackay, Meggan ;
Ding, Linna ;
Gao, Wendy ;
Dooley, Mary Anne ;
Fragoso-Loyo, Hilda ;
Sanchez-Guerrero, Jorge ;
Karp, David R. ;
Olsen, Nancy J. ;
Jolly, Meenakshi ;
Kalunian, Kenneth ;
Kamen, Diane ;
Lee, Iris ;
Levesque, Marc C. ;
Lim, S. Sam ;
Ramos-Remus, Cesar ;
Rovin, Brad H. ;
Sayre, Peter H. ;
Smilek, Dawn E. ;
Tosta, Patti ;
Utset, Tammy O. ;
Venuturupalli, Swamy ;
Winchester, Robert .
ARTHRITIS & RHEUMATOLOGY, 2014, 66 (11) :3096-3104
[3]   Systemic lupus erythematosus in three ethnic groups.: XII.: Risk factors for lupus nephritis after diagnosis [J].
Bastian, HM ;
Roseman, JM ;
McGwin, G ;
Alarcón, GS ;
Friedman, AW ;
Fessler, BJ ;
Baethge, BA ;
Reveille, JD .
LUPUS, 2002, 11 (03) :152-160
[4]  
Christopher-Stine L, 2004, J RHEUMATOL, V31, P1557
[5]   Predictors of Long-Term Renal Outcome in Lupus Nephritis Trials Lessons Learned from the Euro-Lupus Nephritis Cohort [J].
Dall'Era, Maria ;
Cisternas, Miriam G. ;
Smilek, Dawn E. ;
Straub, Laura ;
Houssiau, Frederic A. ;
Cervera, Ricard ;
Rovin, Brad H. ;
Mackay, Meggan .
ARTHRITIS & RHEUMATOLOGY, 2015, 67 (05) :1305-1313
[6]   Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis [J].
Dooley, Mary Anne ;
Jayne, David ;
Ginzler, Ellen M. ;
Isenberg, David ;
Olsen, Nancy J. ;
Wofsy, David ;
Eitner, Frank ;
Appel, Gerald B. ;
Contreras, Gabriel ;
Lisk, Laura ;
Solomons, Neil .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (20) :1886-1895
[7]   Efficacy and Safety of Abatacept in Lupus Nephritis A Twelve-Month, Randomized, Double-Blind Study [J].
Furie, Richard ;
Nicholls, Kathy ;
Cheng, Tien-Tsai ;
Houssiau, Frederic ;
Burgos-Vargas, Ruben ;
Chen, Shun-Le ;
Hillson, Jan L. ;
Meadows-Shropshire, Stephanie ;
Kinaszczuk, Michael ;
Merrill, Joan T. .
ARTHRITIS & RHEUMATOLOGY, 2014, 66 (02) :379-389
[8]   Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis [J].
Ginzler, EM ;
Dooley, MA ;
Aranow, C ;
Kim, MY ;
Buyon, J ;
Merrill, JT ;
Petri, M ;
Gilkeson, GS ;
Wallace, DJ ;
Weisman, MH ;
Appel, GB .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (21) :2219-2228
[9]  
Gladman DD, 2002, J RHEUMATOL, V29, P288
[10]   Induction and Maintenance Treatment of Proliferative Lupus Nephritis: A Meta-analysis of Randomized Controlled Trials [J].
Henderson, Lorna K. ;
Masson, Philip ;
Craig, Jonathan C. ;
Roberts, Matthew A. ;
Flanc, Robert S. ;
Strippoli, Giovanni F. M. ;
Webster, Angela C. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2013, 61 (01) :74-87